v3 Template
T

The Parker Institute for Cancer Immunotherapy

Healthcare ~340 employees
Founded
--
Employees (Est.)
~340
17 leaders known
Total Funding
$125.0M
Funding Rounds
1
Last Funding
2024-07-18

About The Parker Institute for Cancer Immunotherapy

The Parker Institute for Cancer Immunotherapy (PICI) is dedicated to developing breakthrough immune therapies with the mission to turn all cancers into curable diseases faster. They operate as an active research institute, focusing on removing barriers, encouraging collaboration, and transforming ideas into real-world cancer treatments.

Products & Services

Cancer Immunotherapy Research:Focused on advancing immune therapies through collaborative research and innovative models to treat cancer.
Early Career Researcher Awards:Support for the next generation of scientific leaders in cancer immunotherapy through funding and recognition.
Strategic Partnerships:Collaborations with pharma, biotech, and nonprofit entities to enhance cancer treatment development.

Specialties

Cancer Immunotherapy Immune Therapies Collaborative Research Models

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Philanthropic Investment
T: -
FT: Philanthropic Investment
A: 125000000
MR: -
FA: $125 million
FAN: 125000000
D: 2024-07-18
FD: 2024-07-18
-
Philanthropic Investment Latest
2024-07-18
$125.0M

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

S

Sean Parker

Founder and Chairman, Parker Institute for Cancer Immunotherapy

J

Jeffrey Bluestone

Chief Executive Officer and President, Sonoma BioTherapeutics

T

Tony Coles

Chairperson of Cerevel Therapeutics and Chairman and Chief Executive Officer of TRATE Enterprises

E

Eric Esrailian

Chief, Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at UCLA

M

Margaret Georgiadis

Co-Founder and CEO of Montai Therapeutics

S

Scott Gottlieb

Partner at New Enterprise Associates; Former Commissioner of the U.S. Food and Drug Administration

View 14 more team members with Pro

Unlock Full Team Directory

Recent News

The Parker Institute for Cancer Immunotherapy Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Healthcare
Company Size
~340 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro